Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Related Information
Registry Information

Alternate Title

Phase II Study of Hypofractionated Highly Conformal Radiotherapy With Helical Tomotherapy in Patients With Extracranial Oligometastases

Basic Trial Information

Special Category: NIH Clinical Center trial, NCI Web site featured trial

Trial Description

Purpose:

Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.

This phase II trial is studying how well conformal radiation therapy works in treating patients with metastatic cancer outside the brain.

Eligibility:

Eligibility criteria include the following:

• At least 18 years old
• Measurable disease
• More than 2 weeks since chemotherapy
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will undergo conformal radiation therapy every other day for 5 days (three treatments). They will also undergo an imaging procedure before and after each treatment.

Patients will fill out a pain questionnaire at the beginning of the study and at 1 and 3 months after finishing treatment.

After finishing treatment, patients will be evaluated at 1 and 3 months and every 3 months for up to 1 year.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

NCI - Center for Cancer Research

Deborah Citrin, MD, Principal investigator		Ph: 301-496-5457 Email: citrind@mail.nih.gov

Related Information

Featured trial article

Registry Information
Official Title		A Phase II Study of Hypofractionated Highly Conformal Radiation with Helical Tomotherapy for Extra-Cranial Oligo
Trial Start Date		2007-10-02
Trial Completion Date		2010-05-06
Registered in ClinicalTrials.gov		NCT00550654
Date Submitted to PDQ		2007-10-02
Information Last Verified		2009-06-07

Back to Top